Evidence map›Paper›PMID 31058159›Full record

ArticleFrontiers in nutrition2019

Plasma Ketone and Medium Chain Fatty Acid Response in Humans Consuming Different Medium Chain Triglycerides During a Metabolic Study Day.

Valérie St-Pierre, Camille Vandenberghe, Carolyne-Mary Lowry, Mélanie Fortier, Christian-Alexandre Castellano, Richard Wagner, Stephen C Cunnane

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 4 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 4 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Ca:Mg ratio, medium-chain fatty acids, and the gut microbiome.Clinical nutrition (Edinburgh, Scotland) · 2022
    Trial
  9. A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Acetoacetate suppresses colon cancer via an MR1-MAIT axis.bioRxiv : the preprint server for biology · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Valérie St-PierreResearch Center on Aging, Sherbrooke, QC, Canada.
Camille VandenbergheResearch Center on Aging, Sherbrooke, QC, Canada.
Carolyne-Mary LowryDepartments of Nuclear Medicine and Radiobiology, Université de Sherbrooke, Sherbrooke, QC, Canada.
Mélanie FortierResearch Center on Aging, Sherbrooke, QC, Canada.
Christian-Alexandre CastellanoResearch Center on Aging, Sherbrooke, QC, Canada.
Richard WagnerResearch Center on Aging, Sherbrooke, QC, Canada.
Stephen C CunnaneResearch Center on Aging, Sherbrooke, QC, Canada.
Université de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acetoacetatehumanketonesMCFAMCTβ-hydroxybutyrate

Identifiers

PMID31058159
PMCPMC6481320
OpenAlexW2929221552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.